| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918445 | Radiotherapy and Oncology | 2014 | 5 Pages |
Abstract
We found a safety event rate in HDR brachytherapy of 0.15%. SAV significantly reduced the number of undetected errors in HDR treatment plans compared to MV, and reduced the time required for plan verification.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Antonio L. Damato, Phillip M. Devlin, Mandar S. Bhagwat, Ivan Buzurovic, Scott Friesen, Jorgen L. Hansen, Larissa J. Lee, Christina Molodowitch, Paul L. Nguyen, Desmond A. O'Farrell, Akila N. Viswanathan, Christopher L. Williams, Joseph H. Killoran,